What question did this study set out to answer?

This research aimed to assess survival differences after cancer diagnosis between individuals with and without type 2 diabetes and the role of metformin in influencing these outcomes.

January 16, 2012Diabetes CareOpen Access

Mortality After Incident Cancer in People With and Without Type 2 Diabetes

View Full Paper

Ask AI

Bookmark

Authors

CCCraig J. CurrieBC Cancer Agency CPChris PooleVencore (United States)SJSara Jenkins‐JonesKorea Pharma (South Korea)

Discussion

Member takes

Implication

Retrospective cohort study examines cancer survival in diabetes patients, highlighting treatment effects on mortality.

Key Points

This research aimed to assess survival differences after cancer diagnosis between individuals with and without type 2 diabetes and the role of metformin in influencing these outcomes.
Retrospective cohort study using data from over 350 U.K. primary care practices.
Identified individuals with or without diabetes who developed their first tumor after January 1990.
Cox proportional hazards models analyzed all-cause mortality related to various cancers.
Among 112,408 individuals, 8,392 (7.5%) had type 2 diabetes with increased cancer mortality (hazard ratio 1.09 [95% CI 1.06-1.13]).
Increased mortality observed in breast (1.32 [1.17-1.49]) and prostate cancers (1.19 [1.08-1.31]), but reduced mortality in lung cancer (0.84 [0.77-0.92]).
Metformin monotherapy associated with reduced mortality (0.85 [0.78-0.93]) compared to sulfonylureas and insulin.

Cite This Study

Currie et al. (2012) studied this question.

synapsesocial.com/papers/6a70f2ed6c240de38cdbffd4 https://doi.org/10.2337/dc11-1313

View Full Paper

Ask AI

Bookmark

Mortality After Incident Cancer in People With and Without Type 2 Diabetes

Discussion

Member takes

Implication

Key Points

Cite This Study

Mortality After Incident Cancer in People With and Without Type 2 Diabetes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider